Tomáš Cihlář

Tomáš Cihlář
Born1967 (age 58–59)
Plzeň, Czechoslovakia (now Czech Republic)
Alma materUniversity of Chemistry and Technology, Prague
OccupationsBiochemist, virologist
Known forRemdesivir, tenofovir disoproxil

Tomáš Cihlář (born 1967) is a Czech biochemist known for his role in the development of remdesivir. A specialist in virology, Cihlář holds the positions of senior director, biology, and vice-president at American pharmaceutical company Gilead Sciences. As a student, Cihlář assisted fellow biochemist Antonín Holý in developing Viread, the primary drug used to fight HIV infection.

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.